San Diego, CA -- (SBWIRE) -- 08/04/2015 -- An investigation on behalf of investors of Biogen Inc (NASDAQ:BIIB) shares over potential securities laws violations by Biogen and certain of its directors and officers in connection certain financial statements was announced.

Investors who purchased shares of Biogen Inc (NASDAQ:BIIB), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Biogen Inc (NASDAQ:BIIB) concerning whether a series of statements by Biogen regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On July 24, 2015, pre-market, Biogen Inc reported its second quarter 2015 results and updated its full-year financial guidance from 14-16% to 6-8% above 2014 revenues. Shares of Biogen Inc (NASDAQ:BIIB) declined to as low as $299.76 per share on July 24, 2015.

On July 31, 2015, NASDAQ:BIIB closed at $318.78 per share.

Those who purchased shares of Biogen Inc (NASDAQ:BIIB) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com